Cell Source, Inc. (CLCS): Shares Outstanding

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2013-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

45.04M
As of 2024-12-31
45.04M
As of 2025-03-31
+9.4%
3-year compound annual growth
+10.7%
5-year compound annual growth
+6.7%
10-year compound annual growth
2012-12-31: 5.50M2013-12-31: 14.16M2014-12-31: 23.58M2015-12-31: 23.93M2016-12-31: 24.68M2017-12-31: 25.35M2018-12-31: 26.08M2019-12-31: 27.08M2020-12-31: 32.54M2021-12-31: 34.36M2022-12-31: 36.08M2023-12-31: 39.83M2024-12-31: 45.04M45.04M
2012-12-31 Shares Outstanding (shares) 2024-12-31
Period endedShares OutstandingChange YoYSource filing
2024-12-3145.04M+13.1%2026-04-07, Balance as of period end
2023-12-3139.83M+10.4%2026-04-07, Balance as of period end
2022-12-3136.08M+5.0%2024-06-24, Balance as of period end
2021-12-3134.36M+5.6%2023-08-08, Balance as of period end
2020-12-3132.54M+20.2%2022-04-15, Balance as of period end
2019-12-3127.08M+3.8%2021-04-15, Balance as of period end
2018-12-3126.08M+2.9%2020-03-30, Balance as of period end
2017-12-3125.35M+2.7%2019-04-01, Balance as of period end
2016-12-3124.68M+3.1%2018-07-25, Balance as of period end
2015-12-3123.93M+1.5%2018-07-25, Balance as of period end
2014-12-3123.58M+66.6%2016-04-14, Balance as of period end
2013-12-3114.16Mn/c2015-03-13, Balance as of period end
2012-12-315.50Mn/a2014-03-25, Balance as of period end